Oncotarget

Research Papers:

Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia

Qianqian Hou, Fei Liao, Shouyue Zhang, Duyu Zhang, Yan Zhang, Xueyan Zhou, Xuyang Xia, Yuanxin Ye, Hanshuo Yang, Zhaozhi Li, Leiming Wang, Xi Wang, Zhigui Ma, Yiping Zhu, Liang Ouyang, Yuelan Wang, Hui Zhang, Li Yang, Heng Xu _ and Yang Shu

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:36040-36053. https://doi.org/10.18632/oncotarget.16424

Metrics: PDF 1027 views  |   HTML 1219 views  |   ?  


Abstract

Qianqian Hou1,*, Fei Liao1,*, Shouyue Zhang1,*, Duyu Zhang1,*, Yan Zhang2, Xueyan Zhou1, Xuyang Xia1, Yuanxin Ye8, Hanshuo Yang3, Zhaozhi Li1, Leiming Wang4, Xi Wang5, Zhigui Ma6, Yiping Zhu6, Liang Ouyang3, Yuelan Wang1, Hui Zhang7, Li Yang3, Heng Xu1,8, Yang Shu1

1Department of Laboratory Medicine, Precision Medicine Center, State Key Laboratory of Biotherapy and Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China

2Department of Thoracic Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China

3State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China

4Department of Molecular Biology, Baylor College of Medicine, Houston, Texas, USA

5Department of Microbiology, Immunology and Molecular Genetics, University of California at Los Angles, Los Angles, California, USA

6Department of Pediatric Hematology/Oncology, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China

7Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA

8Department of Laboratory Medicine, Research Center of Clinical Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China

*These authors contributed equally to this work

Correspondence to:

Heng Xu, email: xuheng81916@scu.edu.cn

Yang Shu, email: shuyang1986@gmail.com

Keywords: GATA3, acute lymphoblastic leukemia, tissue-specific regulation network, microarray datasets

Received: February 21, 2017     Accepted: March 11, 2017     Published: March 21, 2017

ABSTRACT

GATA3 polymorphisms were reported to be significantly associated with susceptibility of pediatric B-lineage acute lymphoblastic leukemia (ALL), by impacting on GATA3 expression. We noticed that ALL-related GATA3 polymorphism located around in the tissue-specific enhancer, and significantly associated with GATA3 expression. Although the regulatory network of GATA3 has been well reported in T cells, the functional status of GATA3 is poorly understood in B-ALL. We thus conducted genome-wide gene expression association analyses to reveal expression associated genes and pathways in nine independent B-ALL patient cohorts. In B-ALL patients, 173 candidates were identified to be significantly associated with GATA3 expression, including some reported GATA3-related genes (e.g., ITM2A) and well-known tumor-related genes (e.g., STAT4). Some of the candidates exhibit tissue-specific and subtype-specific association with GATA3. Through overexpression and down-regulation of GATA3 in leukemia cell lines, several reported and novel GATA3 regulated genes were validated. Moreover, association of GATA3 expression and its targets can be impacted by SNPs (e.g., rs4894953), which locate in the potential GATA3 binding motif. Our findings suggest that GATA3 may be involved in multiple tumor-related pathways (e.g., STAT/JAK pathway) in B-ALL to impact leukemogenesis through epigenetic regulation.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16424